IP Verse

Müller, Christian competitive analysis

Explore patent oppositions filed by Müller, Christian against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026

Patent Number	Title	Applicant	Opposition Date
EP2729126	Liposomes Having Useful N:P Ratio For Delivery Of Rna Molecules	GLAXOSMITHKLINE BIOLOGICALS SA	Sep 23, 2021
EP3090060	Methods For Rna Analysis	CUREVAC	Nov 19, 2019
EP2750707	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	GLAXOSMITHKLINE BIOLOGICALS SA	Jul 23, 2019
EP1926813	Cell Populations Having Immunoregulatory Activity, Method For Isolation And Uses	CELLERIX	Mar 8, 2017
EP2569633	Compositions And Methods Of Identifying Tumor Specific Neoantigens	DANA FARBER CANCER INSTITUTE	Nov 9, 2016
EP2292737	Use Of Adipose Tissue-Derived Stromal Stem Cells In Treating Fistula	CELLERIX	Dec 23, 2015
EP2292736	Identification And Insolation Of Multipotent Cells From Non-Osteochondral Mesenchymal Tissue	CELLERIX	Oct 21, 2015

Discover the latest PTAB cases involving Müller, Christian, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Müller, Christian with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
MÜLLER, CHRISTIAN	7	-	-	-
CELLERIX	-	5	-	-
GLAXOSMITHKLINE BIOLOGICALS SA	29	101	2	9
TIGENIX	-	5	-	-